Entries by april@madhedgefundtrader.com

March 19, 2025

Mad Hedge Technology Letter March 19, 2025 Fiat Lux   Featured Trade: (ONE TO KEEP AN EYE OUT FOR) (ORCL), (TIKTOK)

One To Keep An Eye Out For

The U.S. administration has kicked around the idea of Oracle (ORCL) chairman Larry Ellison as a possible buyer to one of the hottest social media assets TikTok. Oracle isn’t intending to outright acquire a majority stake, but their involvement shows that Oracle is at the seat with the big boys in tech and that seat

Trade Alert - (NVDA) March 21, 2025 - EXPIRATION AT MAX PROFIT

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

March 19, 2025

  (THE TARIFF FIX) March 19, 2025   Hello everyone     We all know that markets and uncertainty don’t mix well.  And right now, there is a lot of uncertainty surrounding U.S. trade policy. While the Trump administration tariffs on Mexico and Canada have been delayed for a month, the 10% tariff on Chinese

Trade Alert - (GLD) March 21, 2025 - EXPIRATION AT MAX PROFIT

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.

March 18, 2025

Mad Hedge Biotech and Healthcare Letter March 18, 2025 Fiat Lux   Featured Trade: (WHEN THE MARKET GIVES BACK WHAT IT ONCE TOOK AWAY) (ABT), (ISRG), (SYK), (BSX)

When The Market Gives Back What It Once Took Away

If Wall Street had a confessional booth, I'd be first in line. "Forgive me, market gods, for I underestimated how quickly sentiment could shift." When I last wrote about Abbott Laboratories (ABT), the market was treating this medical device powerhouse like last week's leftovers—despite growth that would make most CEOs weep with joy. Fast forward

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.